S33084 is a potent, selective, and competitive antagonist at dopamine D(3)-receptors. References: Mela F, Millan MJ, Brocco M, Morari M. The selective D(3) receptor antagonist, S33084, improves parkinsonian-like motor dysfunction but does not affect L-DOPA-induced dyskinesia in 6-hydroxydopamine hemi-lesioned rats. Neuropharmacology. 2010 Feb;58(2):528-36. doi: 10.1016/j.neuropharm.2009.08.017. Epub 2009 Sep 4. PubMed PMID: 19733554.

纯度：≥98%

CAS：273203-30-8